Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

34 results
Display

A Case of Pityriasis Rosea Associated with Leuprolide Acetate

Kim SR, Kim CY

  • KMID: 2301541
  • Korean J Dermatol.
  • 2014 Dec;52(12):917-918.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comments to "A Case of Pityriasis Rosea Associated with Leuprolide Acetate"

Yoon TY

  • KMID: 2132681
  • Korean J Dermatol.
  • 2015 Dec;53(10):818-819.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preliminary Study of Effect of Leuprolide Acetate Treatment on Sexual Fantasy of Sex Offenders

Ahn J, Shim G, Lee J, Lee J, Lee T, Roh I

This study investigated the effect of leuprolide acetate treatment on sex offenders' sexual fantasies and behaviors, as well as on their criminogenic psychological character and the risk of second conviction....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Foreign Body Granuloma Secondary to Leuprorelin Acetate

Lee BI, Lee JY, Kim HO, Park YM

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sterile Abscess Formation Associated with Two Different Forms of Gonadotropin-Releasing Hormone Agonist in Central Precocious Puberty

Kim JM, Shin YL

Long-acting formulations of gonadotropin-releasing hormone (GnRH) agonists are indicated for treating central precocious puberty. Leuprolide acetate and triptorelin acetate are widely used in Korea. Local reactions related to GnRH agonists,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Leuprolide Acetate-induced Foreign Body Granuloma in a Patient with Prostate Cancer

Park SM, Kim JM, Kim GW, Mun JH, Song M, Kim HS, Kim BS, Kim MB, Ko HC

  • KMID: 2344381
  • Korean J Dermatol.
  • 2016 Jul;54(6):477-480.
Leuprolide acetate is an established luteinizing hormone-releasing hormone (LHRH) agonist used as a first-line treatment in advanced prostate cancer. An 80-year-old man presented with a localized erythematous patch with an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of GnRH Analogs Leuprolide-Acetate and Triptorelin on Bone Mineral Density in Girls with Central Precocious Puberty

Bauer S, Nam HK, Rhie YJ, Park SH, Lee KH

  • KMID: 2384068
  • J Korean Soc Pediatr Endocrinol.
  • 2011 Aug;16(2):106-111.
PURPOSE: The objective of this study was to evaluate the effect of gonadotropin releasing hormone analog (GnRHa) treatment on bone mineral density (BMD) in girls with central precocious puberty (CPP)....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Leuprolide Acetate to the Testicular Histopathology of Male Rat

Park TS, Kim DH

  • KMID: 1912687
  • Korean J Urol.
  • 1989 Oct;30(5):655-661.
We performed this study to observe the effects of chronic administration of leuprolide acetate(potent synthetic LHRH analog) to the testicular histopathology of prostatic cancer patient and to the spermatogenesis in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide

Shim M, Bang WJ, Oh CY, Lee YS, Cho JS

PURPOSE: To investigate the changes in testosterone levels and rates of chemical castration following androgen-deprivation therapy (ADT) with goserelin, triptorelin, and leuprolide. MATERIALS AND METHODS: We retrospectively reviewed the medical records...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of the Administration of a LHRH Analog and the Local Testicular Irradiation on the Rat Prostate

Shin KY, Woo YN

  • KMID: 1912685
  • Korean J Urol.
  • 1989 Oct;30(5):642-648.
Recently LHRH analog has been interested in the endocrine management of metastatic prostatic. cancer. But the effect of LHRH analog therapy on the prostate has not been previously documented definitely....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Effects of Leuprorelin (Leuprolide Acetate) in Sexual Offenders with Paraphilia

Choi JH, Lee JW, Lee JK, Jang S, Yoo M, Lee DB, Hong JW, Noh IS, Lim MH

BACKGROUND: This study examined the clinical effects of leuprolide acetate in sexual offenders with paraphilic disorders evaluated by means of objective psychiatric assessment. METHODS: The subjects of this study were seven...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of LHRH Agonist on Erectile Function in the Rabbit

Choi S, Kim TS, Goldstein

  • KMID: 2227029
  • Korean J Androl.
  • 2003 Dec;21(3):145-151.
PURPOSE: The goal of this study was to investigate the effects of luteinizing hormone-releasing hormone(LHRH) agonist treatment on erectile function in an animal model. MATERIALS AND METHODS: New Zealand White male...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
GnRH Agonist Co-treatment for Prevention of Primary Ovarian Insufficiency in Patients with Hematologic Malignancies Undergoing Chemotherapy

Chun S, Ji YI, Joo YD

  • KMID: 2321321
  • J Korean Soc Menopause.
  • 2013 Aug;19(2):93-100.
OBJECTIVES: The aim of this study was to assess the effect of gonadotropin-releasing hormone (GnRH) agonist co-treatment for gonadal protection in patients with hematologic neoplasms undergoing chemotherapy. METHODS: Young premenopausal women...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report

Lee M, Kim TH, Kim SJ, Jee BC

Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathogenesis and Management Guideline of Dysmenorrhea

Kim T

  • KMID: 2272620
  • Korean J Obstet Gynecol.
  • 2005 Jul;48(7):1613-1620.
Dysmenorrhea presents as painful periods that start two to three years after menarche. The pain usually begins when the bleeding starts and lasts for 32-48 hours. The cause of menstrual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty

Kim YJ, Lee HS, Lee YJ, Lim JS, Kim SY, Kim EY, Jin DK, Hwang IT, Hwang JS

PURPOSE: We evaluated the efficacy, safety and psychological aspect of monthly administrations of the gonadotropin-releasing hormone agonists (GnRHa), leuprolide acetate depot (Luphere depot 3.75 mg), in patients with precocious puberty. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density

Cho YH, Um MJ, Kim SJ, Kim SA, Jung H

OBJECTIVES: To evaluate the efficacy of raloxifene in preventing bone loss associated with long term gonadotropin-releasing hormone agonist (GnRH-a) administration. METHODS: Twenty-two premenopausal women with severe endometriosis were treated with leuprolide...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of hyperosmolar nonketotic coma associated with androgen deprivation therapy in prostate cancer

Hong EY, Lee SW, Kang JG, Kim CS, Ihm SH, Yoo HJ, Lee SJ

  • KMID: 1458438
  • Korean J Med.
  • 2010 Nov;79(5):573-576.
During advanced prostate cancer, androgen deprivation therapy (ADT) using gonadotropin-releasing hormone and antiandrogen is an effective treatment modality. Recently, it has been reported that ADT may result in diabetes mellitus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Good Response of a Salivary Duct Carcinoma to Androgen Deprivation Therapy

Lee JM, Lee JA, Lim SY, Kim SM, Lee YH, Yoon JG, Kang EJ

Salivary duct carcinoma (SDC) is a rare, aggressive tumor. Androgen deprivation therapy (ADT) has been shown to have beneficial effects on SDC-expressing androgen receptors (ARs). A 69-year-old male with a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A comparative study of the puberty suppression effect of gonadotropin-releasing hormone agonist in precocious or early puberty girls

Shim KS, Bae CW, Yang YJ

PURPOSE: There has been considerable disagreement regarding the most appropriate dosage of gonadotropin-releasing hormone agonist in cases of central precocious puberty. The aim of this study was to determine the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr